Exact Sciences Corporation (EXAS): Price and Financial Metrics
Exact Sciences Corporation (EXAS)
Today's Latest Price: $83.80 USD
1.64 (2.00%)
Updated Nov 19 12:00am
Add EXAS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 51 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
EXAS Stock Summary
- EXAS has a market capitalization of $11,487,543,235 -- more than approximately 85.85% of US stocks.
- EXAS's price/sales ratio is 15.87; that's higher than the P/S ratio of 93.34% of US stocks.
- Revenue growth over the past 12 months for Exact Sciences Corp comes in at 81.43%, a number that bests 93.39% of the US stocks we're tracking.
- Stocks that are quantitatively similar to EXAS, based on their financial statements, market capitalization, and price volatility, are NVRO, AMRN, IRTC, VCYT, and ATRC.
- EXAS's SEC filings can be seen here. And to visit Exact Sciences Corp's official web site, go to www.exactsciences.com.
EXAS Daily Price Range
EXAS 52-Week Price Range
EXAS Stock Price Chart More Charts
EXAS Price/Volume Stats
| Current price | $83.80 |
| Prev. close | $82.16 |
| Day low | $82.09 |
| Day high | $85.25 |
| 50-day MA | $92.18 |
| 200-day MA | $100.64 |
| 52-week high | $123.99 |
| 52-week low | $53.06 |
| Volume | 2,179,800 |
| Avg. volume | 1,840,074 |
| Dividend yield | N/A |
| Market Cap | 10.88B |
Exact Sciences Corporation (EXAS) Company Bio
Exact Sciences is a molecular diagnostics company focused on gastrointestinal cancers. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. The company was founded in 1995 and is based in Madison, Wisconsin.
Top Stories View All
Is Cannabis Stock Aurora Cannabis (ACB) a Buy?
Best & Worst Performing Stock Industries for November 19, 2019
Best & Worst Performing Small Cap Stocks for November 19, 2019
Best & Worst Performing Mid Cap Stocks for November 19, 2019
Best & Worst Performing Large Cap Stocks for November 19, 2019
View All Top Stories
Loading social stream, please wait...